旅行疫苗市場規模- 按成分(單一和組合疫苗)、疾病類型(甲型和乙型肝炎、流感、百白破、黃熱病、腦膜炎球菌、傷寒、狂犬病、麻疹和腮腺炎)、應用、全球預測,2023-2032年
市場調查報告書
商品編碼
1368717

旅行疫苗市場規模- 按成分(單一和組合疫苗)、疾病類型(甲型和乙型肝炎、流感、百白破、黃熱病、腦膜炎球菌、傷寒、狂犬病、麻疹和腮腺炎)、應用、全球預測,2023-2032年

Travel Vaccines Market Size - By Composition (Mono & Combination Vaccines), Disease Type (Hepatitis A & B, Influenza, DPT, Yellow Fever, Meningococcal, Typhoid, Rabies, Measles & Mumps), Application, Global Forecast, 2023-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

受麻疹和登革熱等幾種新傳染病的湧入和現有傳染病死灰復燃的推動,旅行疫苗市場規模從 2023 年到 2032 年的年複合成長率預計將達到 9.7%。根據疾病管制與預防中心的數據,2021 年麻疹估計導致 128,000 人死亡,其中大部分是兒童。

旨在改進現有旅行疫苗和開發新疫苗的持續研發活動和投資也將有助於產業成長。舉例來說,2023年5月,巴伐利亞北歐公司投資2.74億美元收購Emergent BioSolutions的旅遊疫苗組合,以加強其研發和製造能力。人們越來越關注創造更方便的單劑量疫苗以提供更廣泛的保護,這也將增加產品的採用。

整個旅行疫苗產業根據成分、疾病類型、應用和地區進行細分。

就成分而言,2023-2032年組合旅行疫苗的需求可能會出現可觀的年複合成長率。組合疫苗用於簡化疫苗接種過程並提高旅行者的依從性。這些疫苗對於在不同地區有接觸多種傳染病風險的旅客特別有益,因為它們限制了多次疫苗接種的需要,同時提供了對多種疾病的保護。消費者越來越傾向於減少所需的注射和注射次數,這也將有利於產品的吸收。

就疾病類型而言,預計到2032 年,乙型肝炎細分市場的旅遊疫苗市場將實現顯著的年複合成長率。隨著醫療旅遊業的快速成長,醫療機構越來越重視患者和醫療遊客對乙型肝炎疫苗的需求。限制感染傳播。乙型肝炎盛行率較高(主要在非洲和亞洲),加上與工作相關的旅行率上升,將推動該細分市場的成長。根據世界衛生組織的數據,2022 年將有近 9,100 萬非洲人感染B型或C型肝炎。

從地區來看,由於中產階級人口的快速成長和對國際旅行的偏好不斷增加,預計到 2032 年,亞太地區旅行疫苗市場規模將出現可觀的年複合成長率。該地區多個政府正在不斷審查和更新與旅遊疫苗相關的法規,例如入境要求和疫苗接種證明。醫療保健組織對旅遊疫苗重要性的日益重視也將有利於區域市場的擴張。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:旅行疫苗市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 增加旅行和旅遊業
      • 提高旅行者對疫苗可預防疾病的認知
      • 政府和其他組織為加強旅行安全所採取的舉措
    • 產業陷阱與挑戰
      • 旅行疫苗接種費用高
      • 與旅行疫苗相關的副作用
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 全球公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章:旅行疫苗市場:依構成,2018 年 - 2032 年

  • 主要動向:按構成
  • 單一疫苗
  • 聯合疫苗

第 6 章:旅遊疫苗市場:依疾病類型分類,2018 年 - 2032 年

  • 主要動力向:依疾病類型
  • 甲型肝炎
  • B型肝炎
  • 流感
  • 白喉、百日咳、破傷風 (DPT)
  • 狂犬病
  • 黃熱病
  • 傷寒
  • 麻疹和腮腺炎
  • 腦膜炎球菌
  • 其他疾病疫苗

第 7 章:旅遊疫苗市場:按應用,2018 - 2032

  • 主要動向:按應用
  • 出境遊
  • 國內旅遊

第 8 章:旅行疫苗市場:按地區分類,2018 年 - 2032 年

  • 主要動向:按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 9 章:公司簡介

  • GSK plc
  • Sanofi
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.
  • CSL Ltd.
  • Qiagen N.V.
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Valneva Inc
Product Code: 6573

Travel Vaccines Market size is poised to record 9.7% CAGR from 2023-2032, driven by the influx of several new infectious diseases and the resurgence of existing ones, including measles and dengue. As per the Centers for Disease Control and Prevention, measles killed an estimated 128,000 people, mostly children in 2021.

The ongoing R&D activities and investments aimed at improving the existing travel vaccines and developing new vaccines will also assist the industry growth. To cite an instance, in May 2023, Bavarian Nordic invested $274M to acquire travel vaccine portfolio of Emergent BioSolutions in a bid to strengthen its R&D and manufacturing capabilities. The growing focus on the creation of more convenient, single-dose vaccines to offer broader protection will also add to the product adoption.

The overall travel vaccines industry is segmented based on composition, disease type, application, and region.

In terms of composition, the demand for combination travel vaccines may record appreciable CAGR from 2023-2032. Combination vaccines are used for simplifying the vaccination process and enhance compliance among travelers. These vaccines are especially beneficial for travelers at risk of exposure to several infectious diseases in different regions as they limit the need for multiple vaccinations while rendering protection against multiple diseases. The rising consumer preference for reducing the number of required injections and shots will also prove favorable for the product uptake.

With respect to disease type, the travel vaccines market from the hepatitis B segment is expected to garner significant CAGR through 2032. With the rapid growth in medical tourism, healthcare facilities are highlighting the requirement for hepatitis B vaccines for patients as well as medical tourists to limit the infection transmission. The higher prevalence of hepatitis B, mainly in Africa and Asia along with the rising rate of work-related travel will drive the segment growth. As per the WHO, nearly 91 million Africans were infected with Hepatitis B or C in 2022.

Regionally, APAC travel vaccines market size is projected to record appreciable CAGR through 2032 due to the rapid growth of the middle-class population and the rising preference for international travel. Several governments in the region are constantly reviewing and updating regulations related to travel vaccines, such as entry requirements and vaccination certificates. The surging emphasis laid by healthcare organizations about the importance of travel vaccinations will also prove favorable for the regional market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Travel vaccines industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Composition trends
    • 2.1.4 Disease type trends
    • 2.1.5 Application trends

Chapter 3 Travel Vaccines Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing travel & tourism
      • 3.2.1.2 Increasing awareness about vaccine-preventable diseases among travelers
      • 3.2.1.3 Initiatives by governments and other organizations to enhance travel safety
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of travel vaccinations
      • 3.2.2.2 Side effects associated with travel vaccines
  • 3.3 Growth potential analysis
    • 3.3.1 By composition
    • 3.3.2 By disease type
    • 3.3.3 By application
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global company market share analysis, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Travel Vaccines Market, By Composition, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by composition
  • 5.2 Mono vaccines
  • 5.3 Combination vaccines

Chapter 6 Travel Vaccines Market, By Disease Type, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by disease type
  • 6.2 Hepatitis A
  • 6.3 Hepatitis B
  • 6.4 Influenza
  • 6.5 Diphtheria pertussis tetanus (DPT)
  • 6.6 Rabies
  • 6.7 Yellow fever
  • 6.8 Typhoid
  • 6.9 Measles and mumps
  • 6.10 Meningococcal
  • 6.11 Other disease vaccines

Chapter 7 Travel Vaccines Market, By Application, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Outbound travel
  • 7.3 Domestic travel

Chapter 8 Travel Vaccines Market, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 GSK plc
  • 9.2 Sanofi
  • 9.3 Janssen Pharmaceuticals Inc.
  • 9.4 Pfizer Inc.
  • 9.5 CSL Ltd.
  • 9.6 Qiagen N.V.
  • 9.7 AstraZeneca
  • 9.8 F. Hoffmann-La Roche Ltd
  • 9.9 Abbott Laboratories
  • 9.10 Valneva Inc

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by composition (2022)
  • TABLE 3 Market revenue, by disease type (2022)
  • TABLE 4 Market revenue, by application (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global travel vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global travel vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 9 Global travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 10 Global travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 11 Global travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 12 Global travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 13 Global travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 14 Industry impact forces
  • TABLE 15 Mono vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 16 Mono vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 17 Combination vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 18 Combination vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 19 Hepatitis A market size, by region, 2018 - 2022 (USD Million)
  • TABLE 20 Hepatitis A market size, by region, 2023 - 2032 (USD Million)
  • TABLE 21 Hepatitis B market size, by region, 2018 - 2022 (USD Million)
  • TABLE 22 Hepatitis B market size, by region, 2023 - 2032 (USD Million)
  • TABLE 23 Influenza market size, by region, 2018 - 2022 (USD Million)
  • TABLE 24 Influenza market size, by region, 2023 - 2032 (USD Million)
  • TABLE 25 Diphtheria pertussis tetanus (DPT) market size, by region, 2018 - 2022 (USD Million)
  • TABLE 26 Diphtheria pertussis tetanus (DPT) market size, by region, 2023 - 2032 (USD Million)
  • TABLE 27 Rabies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 28 Rabies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 29 Yellow fever market size, by region, 2018 - 2022 (USD Million)
  • TABLE 30 Yellow fever market size, by region, 2023 - 2032 (USD Million)
  • TABLE 31 Typhoid market size, by region, 2018 - 2022 (USD Million)
  • TABLE 32 Typhoid market size, by region, 2023 - 2032 (USD Million)
  • TABLE 33 Measles and mumps market size, by region, 2018 - 2022 (USD Million)
  • TABLE 34 Measles and mumps market size, by region, 2023 - 2032 (USD Million)
  • TABLE 35 Meningococcal market size, by region, 2018 - 2022 (USD Million)
  • TABLE 36 Meningococcal market size, by region, 2023 - 2032 (USD Million)
  • TABLE 37 Other disease vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 38 Other disease vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 39 Outbound travel vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 40 Outbound travel vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 41 Domestic travel vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 42 Domestic travel vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 43 North America travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 44 North America travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 45 North America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 46 North America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 47 North America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 48 North America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 49 North America travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 50 North America travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 51 U.S. travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 52 U.S. travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 53 U.S. travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 54 U.S. travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 55 U.S. travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 56 U.S. travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 57 Canada travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 58 Canada travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 59 Canada travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 60 Canada travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 61 Canada travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 62 Canada travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 63 Europe travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 64 Europe travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 65 Europe travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 66 Europe travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 67 Europe travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 68 Europe travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 69 Europe travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 70 Europe travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 71 Germany travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 72 Germany travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 73 Germany travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 74 Germany travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 75 Germany travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 76 Germany travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 77 UK travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 78 UK travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 79 UK travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 80 UK travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 81 UK travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 82 UK travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 83 France travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 84 France travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 85 France travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 86 France travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 87 France travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 88 France travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 89 Spain travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 90 Spain travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 91 Spain travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 92 Spain travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 93 Spain travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 94 Spain travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 95 Italy travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 96 Italy travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 97 Italy travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 98 Italy travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 99 Italy travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 100 Italy travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 101 Rest of Europe travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 102 Rest of Europe travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 103 Rest of Europe travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 104 Rest of Europe travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 105 Rest of Europe travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 106 Rest of Europe travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 107 Asia Pacific travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 108 Asia Pacific travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 109 Asia Pacific travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 110 Asia Pacific travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 111 Asia Pacific travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 112 Asia Pacific travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 113 Asia Pacific travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 114 Asia Pacific travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 115 China travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 116 China travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 117 China travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 118 China travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 119 China travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 120 China travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 121 Japan travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 122 Japan travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 123 Japan travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 124 Japan travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 125 Japan travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 126 Japan travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 127 India travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 128 India travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 129 India travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 130 India travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 131 India travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 132 India travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 133 Australia travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 134 Australia travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 135 Australia travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 136 Australia travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 137 Australia travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 138 Australia travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Asia Pacific travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Asia Pacific travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 141 Rest of Asia Pacific travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 142 Rest of Asia Pacific travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 143 Rest of Asia Pacific travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 144 Rest of Asia Pacific travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 145 Latin America travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 146 Latin America travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 147 Latin America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 148 Latin America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 149 Latin America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 150 Latin America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 151 Latin America travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 152 Latin America travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 153 Brazil travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 154 Brazil travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 155 Brazil travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 156 Brazil travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 157 Brazil travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 158 Brazil travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 159 Mexico travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 160 Mexico travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 161 Mexico travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 162 Mexico travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 163 Mexico travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 164 Mexico travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 165 Rest of Latin America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 166 Rest of Latin America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 167 Rest of Latin America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 168 Rest of Latin America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 169 Rest of Latin America travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 170 Rest of Latin America travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 171 Middle East & Africa travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 172 Middle East & Africa travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 173 Middle East & Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 174 Middle East & Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 175 Middle East & Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 176 Middle East & Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 177 Middle East & Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 178 Middle East & Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 179 South Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 180 South Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 181 South Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 182 South Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 183 South Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 184 South Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 185 Saudi Arabia travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 186 Saudi Arabia travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 187 Saudi Arabia travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 188 Saudi Arabia travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 189 Saudi Arabia travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 190 Saudi Arabia travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Middle East & Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Middle East & Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 193 Rest of Middle East & Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 194 Rest of Middle East & Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 195 Rest of Middle East & Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 196 Rest of Middle East & Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Travel vaccines industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by composition
  • FIG 8 Growth potential analysis, by disease type
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Global company market share analysis, 2022
  • FIG 14 Competitive positioning matrix, 2022
  • FIG 15 Strategic dashboard, 2022